Supply of Cancer Treatment and Immunomodulatory Drugs

This contract involves the ongoing supply of medicinal products used in drug programs and chemotherapy for the Independent Public Healthcare Institution, Specialist Hospital No. 3 in Rybnik, Poland. Suppliers are required to refer to Annex 1.1 for the detailed specifications of the supplies, which is included in the Terms of Reference. Additional contract conditions are outlined in Annex 2, which contains the draft contractual provisions that will be incorporated into the final agreement. Contracts for the awarded packages will be established upon the conclusion of this procurement process, with a validity period until December 31, 2025. The buyer allows for partial bids, meaning the contract is divided into three parts (packages). Suppliers may submit bids for selected parts (packages), but they must provide pricing for the complete scope specified by the buyer within each part (package). According to Article 139 of the Public Procurement Law, the buyer will first evaluate and assess the bids, followed by the qualification of the highest-rated supplier in each package, ensuring there are no grounds for exclusion and that the participation conditions are met. In compliance with Article 24, paragraph 6 of the Whistleblower Protection Act, the buyer informs that an internal procedure for reporting legal violations and taking subsequent actions has been adopted at the Independent Public Healthcare Institution, Specialist Hospital No. 3 in Rybnik. The procedure details are available at https://www.szpital.rybnik.pl/zglaszanie-nieprawidlowosci.